Elevance Health (ELV)

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-07-17 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Elevance Health, Inc. (ELV) CIK: 0001156039 --- Reporting Owner --- Name: BOUDREAUX GAIL CIK: 0001287920 Role: Director, Officer (President and CEO) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-07-17 | Code: P (Open market purchase) Shares: +680 | Price: $366.41 Total Value: $249,158.80 Shares Owned After: 169,931 | Ownership: D (Direct) Footnotes: [F1] This transaction was executed in multiple purchases at prices ranging from $366.14 to $366.48. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. [Transaction #2] Security: Common Stock Date: 2026-07-17 | Code: P (Open market purchase) Shares: +2,045 | Price: $368.25 Total Value: $753,071.25 Shares Owned After: 171,976 | Ownership: D (Direct) Footnotes: [F2] This transaction was executed in multiple purchases at prices ranging from $367.76 to $368.69. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. --- Holdings --- [Holding #1] Security: Common Stock Ownership: I (Indirect) --- Footnotes (Complete Index) --- F1: This transaction was executed in multiple purchases at prices ranging from $366.14 to $366.48. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2: This transaction was executed in multiple purchases at prices ranging from $367.76 to $368.69. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. --- Signature --- /s/ /s/ Kathleen S. Kiefer, Attorney in fact (2026-07-17)